Caverject Impulse
- Product NDC
- 0009-5182
- 11-digit product format
- 000095182
- Labeler code
- 0009
- Product ID
- 0009-5182_eeb7c131-8178-44e1-b266-6306dc162a9b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alprostadil
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRACAVERNOUS
- Labeler
- Pharmacia & Upjohn Company LLC
- Application
- NDA021212
- Marketing category
- NDA
- Marketing start
- 2002-06-11
- Substance
- ALPROSTADIL
- Active strength
- 20 ug/.5mL
- Pharmacologic classes
- Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Caverject Impulse
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALPROSTADIL | 20 ug/.5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | F5TD010360 |
| Rxcui | 763470, 763472, 763473, 763474 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0009-5182-01 | Caverject Impulse | 2 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 2 | | 16 |
| 0009-5182-11 | Caverject Impulse | 0.5 mL in 1 SYRINGE | INJECTION, POWDER, LYOPHILIZED, | 0.5 | | 16 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ALPROSTADIL | ACTIVE INGREDIENT | F5TD010360 | CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| ALPROSTADIL | ACTIVE MOIETY | F5TD010360 | CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| ALFADEX | INACTIVE INGREDIENT | Z1LH97KTRM | CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0009-5182 | CAVERJECT IMPULSE (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA & UPJOHN COMPANY LLC] | 16 | Current NDC, Legacy NDC, 2 package rows | 20240302_4dec1dbd-c63b-4a1b-81cb-c8d29696cc40.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0009-5182-01 | 00009518201 | 2 SYRINGE in 1 CARTON (0009-5182-01) / .5 mL in 1 SYRINGE (0009-5182-11) | 2 syringe | 2002-06-11 | 0000-00-00 | No | No | Current |
| 0009-5182-11 | 00009518211 | 0.5 mL in 1 SYRINGE | 0.5 ml | | | | | Historical |